Clarification on Medical Necessity for Sex Reassignment Surgery
In response to questions about medical necessity of transgender treatments and sex reassignment surgery, particularly in the U.S.A., where insurance exclusions often prevent access to health care for transgender people, the WPATH Board of Directors has issued a clarification statement which is now available on the Resources page of the WPATH web site. Questions about this statement may be directed to the WPATH office, or to Mr. Jamison Green, Chair of the Public Policy, Advocacy & Liaison Committee of the Board. A parallel statement for international use (without the U.S. insurance focus, and reflecting ICD-10, to which the U.S.A. is not a signatory) is also under development.
Lorem ipsum dolor sit amet, sapien platea morbi dolor lacus nunc, nunc ullamcorper. Felis aliquet egestas vitae, nibh ante quis quis dolor sed mauris. Erat lectus sem ut lobortis, adipiscing ligula eleifend, sodales fringilla mattis dui nullam. Ac massa aliquet.